丹参注射液与3种代糖溶媒配伍的稳定性研究

目的:考察丹参注射液与3种代糖溶媒(果糖注射液、转化糖注射液和转化糖电解质注射液)配伍的稳定性,旨在为糖尿病患者的临床用药提供参考。方法:按临床用药的最大使用量(20 mL·次^-1),制备丹参注射液与3种代糖溶媒(果糖注射液、转化糖注射液和转化糖电解质注射液)的配伍溶液,考察配伍溶液的外观、pH、不溶性微粒、含量测定、紫外光谱及最大吸收波长。结果:在5 h内,溶液性状、不溶性微粒、含量、紫外光谱及最大吸收波长均无显著变化,pH在正常范围(3.5~5.5)内略有变化,且1~2 h内各项数据变化最小,最为稳定。结论:丹参注射液与3种代糖溶媒配伍后,溶液在5 h内基本稳定,建议配伍静置1 h后再输注,以提高输液的安全性。

Objective:To investigate the compatibility stability of Danshen injection and three sugar substitute solvents(fructose injection,invert sugar injection and invert sugar electrolyte injection)to guide rational drug use in diabetic patients. Methods:The compatible solutions of Danshen injection and three kinds of sugar substitute solvents(fructose injection,invert sugar injection and invert sugar and electrolytes injection)were prepared at the maximum medication amount of 20 mL to investigate the appearance,pH,insoluble particles,content,ultraviolet spectrum and the maximum absorbance wavelength of the compatible solution.Results:Within 5 hours,there were no significant changes within the appearance character,insoluble particles,content,ultraviolent spectrum or the maximum wavelength.The value of pH showed a slight change in the normal range(3.5-5.5).Each index had no significant changes in 1-2 hours,indicating the prepared solvent was stable. Conclusion:The solution was basically stable within 5 hours after compatibility of Dashen injection and three sugar substitute solvents.It is suggested to stand the compatible solution for 1 hour before infusion to improve transfusion safety.

[1] LI ZJ(李治军).Analysis of combined injection and 5% glucose injection of several commonly used traditional Chinese medicine(几种常用中药注射剂与5%葡糖糖注射液的配伍分析)[J].Nei Mongol J Tradit Chin Med(内蒙古中医药),2014,21:47
[2] TAN XA(谭晓安),XIAO KY(肖克岳),HE SW(贺书武).Particles in 8 common traditional Chinese drugs for Ⅳ injection(8种常用中药静脉注射液微粒情况考察)[J].Cent South Pharm(中南药学),2007,5(1):47
[3] HUANG JH(黄江虹).Study on related factors influencing the stability of injection of traditional Chinese medicine(影响中药注射剂稳定性的相关因素研究)[J].Lishizhen Med Mater Med Res(时珍国医国药),2007,18(5):1271
[4] ChP 2010.VolⅠ(中国药典2010年版.一部)[S].2010:Appendix(附录)30,36,45,58,63
[5] LIN L(林玲),WAN CX(万长秀).Compatibility of seven kinds of commonly used Chinese medicine injections with 0.9% sodium chloride stability study(7种常用中药注射剂与0.9%氯化钠配伍的稳定性研究)[J].J Nurs Sci(护理学杂志),2013,28(15):48
[6] XU F(徐帆),LIANG XF(梁晓方),SU L(苏莉),et al.Analysis and evaluation of injection stability research methodology(注射剂配伍稳定性研究方法学分析与评价)[J].Chin J Hosp Pharm(中国医院药学杂志),2009,29(10):840
[7] LU MY(陆敏仪),LI M(李梅),ZHOU CY(周崇煜).Summarization of present state of intravenous injection pollution by insoluble particle in China(我国静脉注射剂中微粒的污染原因及控制措施)[J].Chin Tradit Pat Med(中成药),2001,23(3):216